Exploring Quantum Chemical Descriptors and Molecular Docking Approach for Designing Antagonist Search Model for the Glycine/NMDA Receptor Site

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  2017-11-13

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/SLCT.201702291
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• PyGlobal: A toolkit for automated compilation of DFT‐based descriptors

  2016cited by this paper
• Electron density topography based model to explore N-methyl-d-aspartate receptor channel blockers

  2016cited by this paper
• Multiwfn: A multifunctional wavefunction analyzer

  2012cited by this paper
• The Electronegativity and the Global Hardness Are Periodic Properties of Atoms

  2011cited by this paper
• Molecular electrostatic potentials in aromatic substituted 4-hydroxyquino-2-lones: Glycine/NMDA receptor antagonists

  2009cited by this paper
• AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

  2009cited by this paper
• AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

  2009cited by this paper
• Exploring the Limit of Accuracy of the Global Hybrid Meta Density Functional for Main-Group Thermochemistry, Kinetics, and Noncovalent Interactions.

  2008cited by this paper
• Density functionals with broad applicability in chemistry.

  2008cited by this paper
• Electronic structure, charge distribution and vibrational characteristics of glycine/NMDA receptor antagonists

  2007cited by this paper
• Glycine/NMDA receptor antagonists as potential CNS therapeutic agents: ACEA-1021 and related compounds.

  2006cited by this paper
• The NMDA/D1 receptor complex as a new target in drug development.

  2006cited by this paper
• N-methyl-D-aspartate receptor (NMDA) antagonists as potential pain therapeutics.

  2006cited by this paper
• Chemical hardness and density functional theory

  2005cited by this paper
• The NMDA receptor NR2B subunit: a valid therapeutic target for multiple CNS pathologies.

  2004cited by this paper
• NMDA receptor antagonists. A new therapeutic approach for Alzheimer's disease.

  2004cited by this paper
• Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions.

  2003cited by this paper
• NMDA receptor pathways as drug targets

  2002cited by this paper
• Prediction of Glycine/NMDA Receptor Antagonist Inhibition from Molecular Structure

  2002cited by this paper
• Effect of plasma protein binding on in vivo activity and brain penetration of glycine/NMDA receptor antagonists.

  1997cited by this paper
• The N-methyl-D-aspartate (NMDA) receptor glycine site antagonist ACEA 1021 does not produce pathological changes in rat brain.

  1997cited by this paper
• 3'-(Arylmethyl)- and 3'-(aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones: orally active antagonists of the glycine site on the NMDA receptor.

  1994cited by this paper
• Lack of effect of L‐687,414 ((+)‐cis‐4‐methyl‐HA‐966)5 an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology

  1993cited by this paper
• 3-Acyl-4-hydroxyquinolin-2(1H)-ones. Systemically active anticonvulsants acting by antagonism at the glycine site of the N-methyl-D-aspartate receptor complex.

  1993cited by this paper
• Competitive as well as uncompetitive N-methyl-D-aspartate receptor antagonists affect cortical neuronal morphology and cerebral glucose metabolism

  1993cited by this paper
• 3-(2-Carboxyindol-3-yl)propionic acid-based antagonists of the N-methyl-D-aspartic acid receptor associated glycine binding site.

  1992cited by this paper
• 4-Amido-2-carboxytetrahydroquinolines. Structure-activity relationships for antagonism at the glycine site of the NMDA receptor.

  1992cited by this paper
• Characterization of the binding of [3H]L-689,560, an antagonist for the glycine site on the N-methyl-D-aspartate receptor, to rat brain membranes.

  1992cited by this paper
• Kynurenic acid derivatives. Structure-activity relationships for excitatory amino acid antagonism and identification of potent and selective antagonists at the glycine site on the N-methyl-D-aspartate receptor.

  1991cited by this paper
• NMDA antagonist neurotoxicity: mechanism and prevention.

  1991cited by this paper
• Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative.

  1990cited by this paper
• The glycine coagonist site of the NMDA receptor.

  1990cited by this paper
• Interaction of 6-cyano-7-nitroquinoxaline-2,3-dione with the N-methyl-D-aspartate receptor-associated glycine binding site.

  1989cited by this paper
• Quinoxaline derivatives are high-affinity antagonists of the NMDA receptor-associated glycine sites.

  1989cited by this paper
• HA-966 antagonizes N-methyl-D-aspartate receptors through a selective interaction with the glycine modulatory site

  1989cited by this paper
• Indole-2-carboxylic acid: a competitive antagonist of potentiation by glycine at the NMDA receptor.

  1989cited by this paper
• D-cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics.

  1989cited by this paper
• 1-Aminocyclobutane-1-carboxylate (ACBC): a specific antagonist of the N-methyl-D-aspartate receptor coupled glycine receptor.

  1989cited by this paper
• Resolution and synthesis of the individual enantiomers of the glycine antagonist 3-amino-1-hydroxypyrrolidin-2-one (HA-966)

  1989cited by this paper
• A potent antagonist of the strychnine insensitive glycine receptor has anticonvulsant properties.

  1989cited by this paper
• Antagonist profile of 6,7-dichloro-3-hydroxy-2-quinoxalinecarboxylate at excitatory amino acid receptors in the neonatal rat spinal cord.

  1989cited by this paper
• Glycine antagonist action of 1-aminocyclobutane-1-carboxylate (ACBC) in Xenopus oocytes injected with rat brain mRNA.

  1989cited by this paper
• 7‐クロルキヌレン酸はN‐メチル‐D‐アスパラギン酸受容体複合体のグリシン調節部位での選択的きっ抗物質である

  1988cited by this paper
• Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor.

  1988cited by this paper
• 6,7-Dinitro-quinoxaline-2,3-dion and 6-nitro,7-cyano-quinoxaline-2,3-dion antagonise responses to NMDA in the rat spinal cord via an action at the strychnine-insensitive glycine receptor.

  1988cited by this paper
• Cycloleucine competitively antagonizes the strychnine-insensitive glycine receptor.

  1988cited by this paper
• 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex.

  1988cited by this paper
• Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes.

  1988cited by this paper
• Glycine potentiates the NMDA response in cultured mouse brain neurons

  1987cited by this paper
• Absolute electronegativity and hardness correlated with molecular orbital theory.

  1986cited by this paper
• Absolute electronegativity and absolute hardness of Lewis acids and bases

  1985cited by this paper
• Absolute hardness: companion parameter to absolute electronegativity

  1983cited by this paper

• Regenerative marine waste towards CaCO3 nanoformulation for Alzheimer's therapy.

  2023cites this paper